The spacetech scaleup thus increases the value of its Series A round announced in October 2024, which is now worth EUR 4 million

The two scaleups, both B-Corp, join forces to reduce the environmental impact of the means of transport used for travelling

Series A funding helps company develop innovative therapies in oncology, metabolic and renal diseases

Singapore-born startup specializing in ophthalmic innovation also receives capital from Scientifica Venture Capital